Asymchem Laboratories (Tianjin) Co., Ltd. - Laporan Laba Rugi (TTM)

Asymchem Laboratories (Tianjin) Co., Ltd.
CN ˙ SZSE ˙ CNE100002BZ6
CN¥ 108.27 ↑6.55 (6.44%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Asymchem Laboratories (Tianjin) Co., Ltd. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 2,800 3,137 3,438 3,626 3,977 4,632 5,917 7,918 9,508 10,230 10,418 9,810 8,815 7,825 6,976 5,901 5,582 5,805 5,946 6,296
Change (%) 12.01 9.62 5.47 9.67 16.48 27.73 33.82 20.08 7.60 1.83 -5.83 -10.15 -11.23 -10.85 -15.41 -5.40 3.98 2.44 5.88
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 1,449 1,684 1,879 2,003 2,219 2,582 3,267 4,283 5,119 5,398 5,429 4,896 4,180 3,833 3,463 3,234 3,239 3,393 3,488 3,637
Change (%) 16.17 11.60 6.60 10.80 16.37 26.52 31.09 19.51 5.45 0.58 -9.82 -14.63 -8.30 -9.65 -6.62 0.18 4.74 2.80 4.28
% of Revenue 51.75 53.67 54.64 55.23 55.80 55.75 55.22 54.09 53.84 52.76 52.12 49.90 47.42 48.98 49.64 54.80 58.03 58.45 58.66 57.77
Gross Operating Profit 1,351 1,453 1,560 1,624 1,758 2,050 2,649 3,635 4,389 4,833 4,988 4,915 4,635 3,993 3,513 2,667 2,343 2,412 2,458 2,658
Change (%) 7.55 7.32 4.10 8.26 16.62 29.26 37.19 20.75 10.11 3.22 -1.48 -5.69 -13.86 -12.01 -24.08 -12.16 2.94 1.92 8.15
% of Revenue 48.25 46.33 45.36 44.77 44.20 44.25 44.78 45.91 46.16 47.24 47.88 50.10 52.58 51.02 50.36 45.20 41.97 41.55 41.34 42.23
SG&A 392 427 468 471 522 594 673 801 853 1,014 1,009 1,008 1,087 991 1,019 1,016 986 1,074 1,080 1,117
Change (%) 8.94 9.60 0.76 10.74 13.84 13.22 19.10 6.48 18.78 -0.42 -0.11 7.83 -8.89 2.82 -0.21 -3.04 8.98 0.55 3.47
% of Revenue 13.99 13.61 13.61 13.00 13.13 12.83 11.37 10.12 8.98 9.91 9.69 10.28 12.33 12.66 14.60 17.22 17.65 18.50 18.16 17.75
R&D 228 259 288 314 346 387 435 487 572 709 740 769 780 708 715 713 679 614 583 572
Change (%) 13.57 11.04 9.23 10.17 11.99 12.24 11.95 17.58 23.83 4.40 3.91 1.40 -9.23 1.04 -0.30 -4.80 -9.49 -5.14 -1.95
% of Revenue 8.14 8.25 8.36 8.66 8.70 8.37 7.35 6.15 6.02 6.93 7.10 7.84 8.85 9.05 10.25 12.08 12.16 10.59 9.80 9.08
OpEx 2,060 2,369 2,626 2,827 3,061 3,587 4,421 5,598 6,642 7,120 7,169 6,681 6,062 5,605 5,303 5,056 4,984 5,186 5,226 5,408
Change (%) 15.00 10.82 7.67 8.28 17.16 23.26 26.63 18.64 7.20 0.68 -6.80 -9.27 -7.53 -5.39 -4.66 -1.44 4.06 0.77 3.49
% of Revenue 73.57 75.54 76.36 77.96 76.98 77.43 74.72 70.71 69.86 69.60 68.81 68.10 68.77 71.63 76.02 85.68 89.27 89.34 87.89 85.91
Operating Income 740 767 813 799 916 1,046 1,496 2,319 2,866 3,110 3,249 3,129 2,753 2,220 1,673 845 599 619 720 887
Change (%) 3.69 5.92 -1.67 14.56 14.19 43.05 55.08 23.55 8.53 4.46 -3.67 -12.03 -19.37 -24.64 -49.50 -29.10 3.30 16.42 23.19
% of Revenue 26.43 24.46 23.64 22.04 23.02 22.57 25.28 29.29 30.14 30.40 31.19 31.90 31.23 28.37 23.98 14.32 10.73 10.66 12.11 14.09
Interest Expense -5 -4 -4 -4 -4 -7 -11 -14 -91 -11 -7 -6 -6 -6 -6 -8 -10 -12 -13
Change (%) -19.16 0.55 19.51 -5.58 73.23 50.38 30.31 532.85 -88.41 -32.02 -22.84 3.91 -7.82 47.73 13.63 24.20 12.13
% of Revenue -0.16 -0.12 -0.11 -0.12 -0.11 -0.16 -0.19 -0.18 -0.96 -0.10 -0.07 -0.06 -0.08 -0.09 -0.10 -0.15 -0.16 -0.20 -0.21
Net Income 694 720 766 833 908 1,069 1,414 2,380 3,095 3,302 3,433 3,248 2,791 2,269 1,920 1,082 769 949 994 1,067
Change (%) 3.77 6.43 8.80 8.99 17.71 32.27 68.28 30.05 6.66 3.97 -5.38 -14.07 -18.70 -15.35 -43.68 -28.90 23.40 4.70 7.42
% of Revenue 24.77 22.95 22.28 22.98 22.84 23.08 23.90 30.06 32.56 32.27 32.95 33.11 31.66 28.99 27.53 18.33 13.78 16.35 16.71 16.95

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista